Alzheimer’s Disease Treatments and Expectations

Research Objectives:

  • Understand the current treatment landscape for Alzheimer’s Disease patients
  • Explore what physicians know about and expect for products in development for Alzheimer’s Disease

Method: 9-minute MicroSurvey via InCrowd
Crowds: US Neurologists
Sample Size: n=100
Fielding Period: March 10-13, 2019
Screening Criteria:
Qualified respondents are US-based neurologists who:

  • Treat at least 10 Alzheimer’s Disease patients in a typical month
  • Are at least somewhat knowledgeable about products in development for the treatment of Alzheimer’s Disease

One key finding:

  • Responding neurologists tend to treat over 30 Alzheimer’s patients a month across all severity levels (39% mild, 38% moderate, 23% severe).

Download the full report now!

Please fill out the form below to access this content

This field is for validation purposes and should be left unchanged.

Related Resources

Instant Insights – Weight Loss Drugs

Instant Insights – Weight Loss Drugs

Prescriber Perspectives on Weight Loss Drugs in 2023 Examine how healthcare professionals (HCPs) view and prescribe weight loss drugs currently on the market in our new Instant Insights report. Fielded in a single day, this report includes responses from 100 qualified...

read more
Post-ASCO Excitement Report

Post-ASCO Excitement Report

Physician Perspectives on the 2023 ASCO Annual Meeting Curious what doctors thought about ASCO? Nearly 100 oncologists and hematologist oncologists shared with us the findings and developments they were most excited about. Check-out our 2023 Post-ASCO report to...

read more
2023 Q1 – NSCLC Essentials Readout

2023 Q1 – NSCLC Essentials Readout

Adoption of Newly-Approved 1L mNSCLC Regimens Driven by Promotional Activities Promotion plays a major role in the successful launch of a new pharmaceutical product. Companies must develop a marketing strategy that effectively communicates the benefits of the therapy...

read more